Cell Cycle News & Views

Tumor-stroma relationships: Who’s the driver?

Volume 11, Issue 9   May 1, 2012
Page 1753
http://dx.doi.org/10.4161/cc.20185
Authors: Richard F. Wooster

View affiliations

Cell Cycle News & Views to:
AK Witkiewicz, D Whitaker-Menezes, A Dasgupta, NJ Philp, Z Lin, R Gandara, S Sneddon, UE Martinez-Outschoorn, F Sotgia, MP Lisanti. Using the 'reverse Warburg effect' to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle 2012; 11: 1108-17
PMID: 22313602 DOI: 10.4161/cc.11.6.19530

Received: March 19, 2012; Accepted: March 20, 2012

Preview:



Advertisements